Buffett Did Not Sell Any Apple This Quarter, Sold More BofA & Citi, Exited Ulta And Entered Constellation Brands: Full 13F
Earlier this week, and ahead of this week’s 13F filing deadline around 5pm today, we said that in just a few days we would find out how much more AAPL stock Warren Buffet had sold in Q4 following 4 quarters of aggressive selling of the world’s largest company. Moments ago we got the answer when Berkshire released its latest 13F, and which showed that for the first time since 2023, the Oracle of Omaha had not sold any Apple in the past quarter, and held on to 300 million shares of AAPL, equivalent to $75.1 billion in notional value, or equivalent to 28% of the conglomerate’s portfolio, making it Berkshire’s largest stock for yet another quarter.
But while Buffett’s Berkshire did not sell any Apple this quarter, the conglomerate continued selling longtime bet on Bank of America in last year’s final months, which was trimmed by another 117.4 million shares or 14.7%, in Q4, and followed a 23.7% reduction in Q3. Bank of America executives and shareholders have waited months for the update after Berkshire’s prior sales left it with less than 10% and freed it from a requirement to quickly disclose transactions; to their disappointment the selling continued, and left Buffett with $29.9 billion in BAC as of Dec 31, a stake which was worth $31.9 billion as of Friday’s close. Buffett, 94, started trimming the position, which two quarters ago was his second largest after Apple, in mid-July without providing any explanation.
Apple and Bank of America aside, here’s what else Berkshire did in Q4:
It added to its positions in:
- Occidental Petroleum, +8.9 million shares to 264.2 million shares, or $13.05 billion as of Dec 31
- Verisign, +455,844 shares to 13.3 million shares or $2.75 billion as of Dec 31
- SiriusXM, +12.3 million shares to 117.5 million shares, or $2.7 billion as of Dec 31
- Pool Corp, +194,632 shares to 598.689 shares, or $204 million as of Dec 31
It reduced its positions in:
- Liberty Media by 921K shares to 22.7 million shares of $1.7 billion
- Capital One, by 1.65 million shares to 7.45 million shares, or $1.3 billion
- Citigroup, by 40.6 million shares to 14.6 million shares, or $1.03 billion
- T-Mobile, by 322K shares to 4.3 million shares, or $960 million
- Charter Communications, by 830K shares to 1.99 million shares, or $682 million
- Louisiana-Pacific, by 300K shares to 5.665 million, or $586 million
- Nu Holdings, by 46.3 million shares to 40.2 million, or $416.3 million
Finally, Berkshire also initiated a new position in Constellation Brands (5.6 million shares or $1.2 billion), and exited its entire stake in Ulta Beauty, a stock it started acquiring in the second quarter before paring back the position in the following period, as well as its positions in the SPY and VOO ETFs.
Berkshire will release annual earnings, as well as Buffett’s traditional letter to shareholders, later this month.
A full breakdown of Berkshire’s holdings is below.
Tyler Durden Fri, 02/14/2025 – 18:50
Source: https://freedombunker.com/2025/02/14/buffett-did-not-sell-any-apple-this-quarter-sold-more-bofa-citi-exited-ulta-and-entered-constellation-brands-full-13f/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
